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Abstract
Background: The Integrated Management of Childhood Illnesses is the main approach for treating children in
more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate
‘better medicines for children’ into their essential medicines lists and treatment guidelines. WHO regularly provides
generic algorithms for IMCI and publishes the Model Essential Medicines List with child-friendly medicines based on
new evidence for member countries to adopt. However, the status of ‘better medicines for children’ within the
Integrated Management of Childhood Illnesses approach in Uganda has not been studied.
Methods: Qualitative interviews were conducted with: two officials from the ministry of health; two district health
officials and, 22 health workers from public health facilities. Interview transcripts were manually analyzed for
manifest and latent content.
Results: Child-appropriate dosage formulations were not included in the package for the Integrated Management
of Childhood Illnesses and ministry officials attributed this to resource constraints and lack of initial guidance from
the World Health Organization. Underfunding reportedly undercut efforts to: orient health workers; do support
supervision and update treatment guidelines to reflect ‘better medicines for children’. Health workers reported
difficulties in administering tablets and capsules to under-five children and that’s why they preferred liquid oral
dosage formulations, suppositories and injections.
Conclusions: The IMCI strategy in Uganda was not revised to reflect child-appropriate dosage formulations – a
missed opportunity for improving the quality of management of childhood illnesses. Funding was an obstacle to
the integration of child-appropriate dosage formulations. Ministry of health should prioritize funding for the
Integrated Management of Childhood Illnesses and revising the Essential Medicines and Health Supplies List of
Uganda, the Uganda Clinical Guidelines and, the Treatment Charts for the Integrated Management of Childhood
Illnesses to reflect child-appropriate dosage formulations.
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Background
Globally, an estimated 8.1 million children under-five die
every year due to conditions that can be prevented or treated
with evidence-based medicines [1]. In 1995, the World
Health Organization (WHO) and United Nations Children’s
Emergency Fund (UNICEF) introduced the Integrated Man-
agement of Childhood Illnesses (IMCI) strategy to improve
case management skills of health workers to diagnose and
treat the major childhood illnesses. IMCI was meant to ad-
dress three key elements. The first element was to develop
and provide IMCI guidelines to enable health workers im-
prove case management. Therefore, WHO regularly provides
generic algorithms for IMCI to be adopted by countries fol-
lowing their epidemiological situation. WHO also supports
countries in the selection of essential medicines for children
by publishing the Model Essential Medicines List for children
[2]. The second element was to build the capacity of health
workers through training and support supervision to enable
them use the provided IMCI algorithms to identify and treat
illness. The third element was to strengthen the health sys-
tems so as to provide an environment and facilities conducive
for managing children illnesses. This element covers en-
suring that there is availability of priority medicines
for children. Therefore, UNICEF recommends that
governments should improve their health systems to
ensure that the essential drugs are available [3]. Some
studies have concluded that availability of medicines
is a key condition for the success of IMCI [2–6].
In 2007, the 60th World Health Assembly made a
resolution that urged member countries to include ‘bet-
ter medicines for children’ in their essential medicines
lists and clinical guidelines [4]. Following this resolution,
later in 2007 WHO and partners launched the ‘make
medicines child size’ campaign to create more awareness
about child-appropriate dosage formulations [5]. Hence,
it was sensible to integrate child-appropriate dosage for-
mulations into IMCI, a strategy that is used to manage
sick children in more than 100 countries worldwide.
Uganda was among the first countries worldwide to
adopt and scale up IMCI. According to personal com-
munication with a ministry of health official, after pilot-
ing of the strategy in 1995, IMCI was adopted in 1997 as
a national strategy for the management of the common
childhood illnesses. The first phase of implementation of
IMCI included adaptation of the globally recommended
IMCI guidelines to the Ugandan setting and consequent
training of the health workers in selected districts. With
support from the United States Agency for International
Development (USAID), the IMCI approach was first pilot
tested in ten districts in 1996 and a 22 member national
task force was established to coordinate the IMCI activities.
In 1997, the IMCI approach was scaled up nationally.
According to the Uganda Government Heath Sector
Strategic and Investment Plan III (HSSIP III), IMCI was
recognized as the main approach for treating children in
Uganda [6]. Despite that recognition, there are still gaps
in policy provisions for child-appropriate dosage formu-
lations and so far there has been no formal adoption of
these formulations as a policy [7, 8]. Furthermore, there
is still low availability and utilization of the WHO rec-
ommended lifesaving priority medicines for children in
the public health facilities [9].
Despite these gaps, the perspectives: of administrators
at the MoH; district health officials; and, health workers’
practices and experiences of treating children within the
IMCI approach using child-appropriate dosage formula-
tions have not been explored. This paper is premised on
the understanding that IMCI should be the vehicle for
integrating child-appropriate dosage formulations in
those countries where it is being implemented. It is
therefore critical to assess the extent to which IMCI im-
plementation at the facility level reflects the WHA reso-
lution of ‘better medicines for children’. This paper
explores the perspectives of officials from MoH and the
district health department about the integration of ‘bet-
ter medicines for children’ into the IMCI approach. At
the facility level, the paper explores health workers’
knowledge and perspectives about child-appropriate
dosage formulations, their practices and experiences in




The study derives from the 60th WHA resolution of
‘better medicines for children’. Therefore, the focus of
the study was about the level of integration and applica-
tion of the ‘better medicines for children’ concept into
IMCI, the main framework for managing childhood ill-
nesses in Uganda. The study design was also based on
the premise that child-appropriate dosage formulations
such as dispersible tablets, granules, sprinkles and pellets
are the best for improving prescription, dispensing and
administration of medicines to the under-five population
[10]. In this paper, child-appropriate dosage formulations
refer to medicines that are easily adjusted to reflect size,
strengths, state of development, and condition of a child
[10]. WHO recommended dispersible, scored tablets or
the equivalent of the flexible solid oral dosage formula-
tions as the most effective for children [1, 11]. This
study applied these concepts as basis for the formulation
of the analytical framework, the data collection methods
and the tools that were used.
The analytical framework of the study draws from de-
bates about policy processes and factors that influence
success of implementation of policy and its sustainability
[12–14]. Tansella &Thornicroft (2009) highlighted these
factors in relation to how to accelerate the transfer of
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discoveries in health sciences into implementation of
evidence based routine clinical practice. Tansella &Thor-
nicroft articulated three phases of implementation of
evidence based clinical practices: adoption in principle;
early implementation and, persistence of implementation
[12]. This framework helps to explain the process and
context of IMCI adoption, implementation and its impli-
cation on the adoption of child-appropriate dosage for-
mulations in a low income country Uganda. In this
study, facilitators and barriers to the implementation of
the IMCI program are considered. A multi-level analysis
of perspectives is used and covers the national, district
and facility levels.
Study setting
The study was conducted between July and August 2012
in Uganda, a landlocked low income country in the East
African region. In Uganda, IMCI is the main approach
for diagnosing, dispensing and administering medicines
to treat childhood illnesses. Uganda was also among the
first UN member states in sub-Saharan Africa to imple-
ment IMCI as a national program since 1995 [6]. An IMCI
section was included into both the Uganda Clinical Guide-
lines 2010 and 2012 versions [15, 16].
In Uganda, procurement of medicines for public health
facilities is under National Medical Stores (NMS) which
distributes medicines provided in the Essential Medicines
and Health Supplies List of Uganda (EMHSLU) using a
push system. By the time of the study, the latest version of
EMHSLU was that of 2012. Other medicine procurement
and distribution channels included: the Joint Medical Stores
(JMS)-an umbrella organization for the Uganda Catholic
Medical Bureau (UCMB) and Uganda Protestant Medical
Bureau and, a private sector procurement agent called
Medicine Access Uganda Limited (MAUL). Some medi-
cines are also accessed with direct support of donors and
are channeled through some development partners: the
Uganda Health Marketing Group (UHMG); partners funded
by the President’s Emergency Plan for AIDS Relief (PEPFAR);
Malaria Consortium (MC) and, the United Nations (UN)
agencies including UNICEF, the Joint United Nations
Programme onHIVandAIDS (UNAIDS) andWHO.
The Ugandan public health care system is highly
decentralized with districts and health sub-districts play-
ing a key role in the administration of the delivery of
health services. There is a hierarchy of public health fa-
cilities starting with the lowest service delivery point be-
ing at the village level now referred to as Health Center
One (HCI) through to Health Center four (HCIV) at a
county level. Above these there is , the district hospitals,
regional and national referral hospitals at the top [6]. At
HCI, services are provided by volunteers referred to as
Village Health Team (VHTs) who do not have formal
health training. In 2010, the VHTs were given an
additional role of distributing medicines for the inte-
grated community case management (ICCM) of child-
hood illnesses. The Health Center two (HCII) facilities
are largely managed by Nursing Assistants who have
minimal training in the medical field. In most of the
rural facilities in Uganda, Nursing Assistants play a sig-
nificant role in treating children. Health Center three
(HCIII) facilities are supposed to be served by clinical of-
ficers, nurses, midwives and nursing assistants. In reality,
due to staffing challenges at this level, Nursing Assis-
tants still constitute the majority of the health workers.
At Health Center Four (HCIV) level, in addition to the
cadre of staff stated above, there should be at least a
medical doctor. At the district hospital and above, there
are both general doctors and specialists in addition to
other cadres of health staff. In case of children, the spe-
cialists are pediatricians.
Study respondents
Qualitative in-depth interviews were held with: the
Ministry of Health officials; the district health team and,
health workers from the public health facilities. Health
facilities included one national referral hospital and one
regional referral hospital and sixteen lower level rural
based health facilities in Jinja district. In Uganda, the
concept of health workers refers to those people working
in the health system with the qualifications recognized
by government. Rural based health facilities were lower
levels facilities in the rural areas of Jinja district. These
included HCIIs, HCIIIs and HCIVs. Table 1 shows the
categories of respondents and the themes included in
the interview guide for each category.
At the Ministry of Health level, two officials from the
child health division were interviewed. The child health
division was behind the adaption and scaling up IMCI
implementation in the country. The division also spear-
headed the adaptation of the WHO IMCI algorithm, ini-
tial training and support supervision of health workers.
Two health officials from Jinja district in eastern Uganda
were purposively selected to participate in the study.
The district health officials had been part of the early
implementation of IMCI in the district.
At the facility level, five pediatricians were drawn from
Mulago, the biggest national referral hospital located in
the capital city Kampala. The national referral hospital is a
teaching hospital for the Makerere College of Health Sci-
ences. One pediatrician was drawn from Jinja hospital, the
biggest eastern regional referral hospital located in Jinja
town. Despite, the huge pediatric patient load in the re-
gional referral hospital, there are only two pediatricians.
Sixteen lower level health workers were drawn from 16
rural based health facilities in Jinja district.
All the respondents were purposively selected based
on experiences and current responsibilities about the
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implementation of the IMCI strategy. At the facility
level, those found treating children at the time of the
visit were automatically selected for interviews. All inter-
views were held in privacy and in venues preferred by
the respondents. Where it was felt that information sat-
uration was realized we stopped interviewing more of
that category of respondents. There were 16 health
workers from the rural based health facilities. This num-
ber was high because we wanted to get information from
the diverse categories (clinical officers, nurses, midwives
and nursing assistants) who represented different levels
of healthcare.
Jinja district has a population of more than 468,256
people and of these 299,109 (64 %) live in rural areas
[17]. Administratively, the district is subdivided into
seven rural sub-counties, one town council and three di-
visions in the municipality. Like the rest of the country,
there is a hierarchy of health facilities ranging from
Health Centre II to the regional referral hospital as
described elsewhere [9]. Jinja district has a total of 69
health facilities, 49 of which are public, seventeen are
run by NGOs and three are institutional (army, police
and prisons). The major causes of child morbidity and
mortality in the area include malaria (70 %), acute re-
spiratory infections (16 %) and diarrheal diseases (32 %)
[18]. Jinja is also a home of the neglected tropical disease
of schistomiasis which affects both adults and children.
Data collection
Qualitative in-depth interviews were performed using an
unstructured thematic interview guide. For each category
of respondents, as earlier indicated, the key themes
addressed are provided in Table 1. Data was collected by
the first Author (a social scientist) and was assisted by a
Research Assistant who is also a social scientist. All the
interviews were conducted in English by the first au-
thor. On average the interviews lasted between 40 and
60 min.
Data analysis
Interviews were digitally recorded and later transcribed
verbatim, printed and carefully read. The codes were
then applied to the scripts. Data analysis was conducted
manually using a thematic manifest and latent content
analysis [19]. A coding sheet with the key themes was
developed and later applied to the transcribed text. De-
ductive meanings that were theory guided were adopted
from our pre-conceived abstractions and compared with
the primary data. This was based on the understanding
that category names and related codes can be generated
from the already existing concepts, literature and the
phrases used by the informants themselves [20].
Results
The study explored perspectives about the status of
child-appropriate dosage formulations within the IMCI
approach at three levels in Uganda: the central ministry
level; the district level and the health facility level. The
key themes that emerged were as follows:
 Lacking of funding cut across all the three levels and
affected implementation of IMCI
 At the national level, the IMCI strategy had not been
revised to include child-appropriate dosage formulations
Table 1 Respondents and the thematic areas covered
Respondent Number Main themes covered
MoH Program mangers officers) 2 • The historical context and the process of IMCI implementation
• What worked and what did not work with IMCI and child-appropriate dosage formulation
adoption
• The level of integration of the child-appropriate dosage formulation into IMCI approach
• Achievements and limitation of the integration
The district health team 2 • The historical context and the process of IMCI implementation
• Perspective of the child-appropriate dosage formulations
• Experiences of implementation of IMCI and child-appropriate dosage formulations under a
decentralized arrangement
• Financing, support supervision and refresher training
Pediatricians from Mulago hospital 5 • Practices about using child-appropriate dosage formulations to treat children under 5 years
• Available information about child-appropriate dosage formulations
• Coping mechanisms when there are no child-appropriate dosage formulations
Pediatrician from Jinja hospital 1 • Practices about using child-appropriate dosage formulations to treat children under 5 years
• Available information about child-appropriate dosage formulations
• coping mechanisms when there are no child-appropriate dosage formulations
Lower level rural based health
workers
16 • Their perspectives and practices about using child-appropriate dosage formulations to treat
children under 5 years within the IMCI framework
• Available information about child-appropriate dosage formulations and the treatment protocols
• Coping mechanisms when there are no child-appropriate dosage formulations
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 At the district level, the decentralized IMCI
activities were not being implemented and this
weakened the efforts to integrate the
child-appropriate dosage formulation component.
Ironically, re-centralization of medicine procurement
and distribution to the
National Medical Stores (NMS) reversed district’s
discretion to procure child-friendly medicines
 At the facility level, health workers’ faced challenges
of prescribing, dispensing and administering tablets
and capsules to children. They remodeled ways to
ensure that children received appropriate treatment.
Lower level cadres of rural based health workers did
not have sufficient information about the new
treatment policies that might have included
child-appropriate dosage formulations
Resource constraints
The predominant challenge to the integration of child-
appropriate dosage formulations was the insufficient
funding of IMCI activities at the national, district and fa-
cility levels. Table 2 shows that at the national level, re-
source constraints affected planning, development of
relevant policy reforms and budgeting that in turn af-
fected the integration of child-appropriate dosage for-
mulations into the IMCI framework. This in turn had a
spillover negative effect on the implementation of IMCI
at the lower levels. MoH officials reported that due to
lack of funding, it was not possible to revise the IMCI
treatment charts to reflect child-appropriate dosage for-
mulations. During the late implementation phase of
IMCI, the project resources were already exhausted and
when government took over, it failed to sustain most of
the activities.
At the moment we do not have money for continuing
some of the IMCI activities the way we are supposed
to. Donors have shifted ICCM. We have adopted the
IMCI approach as a routine but we do not have needed
resources to sustain some of the core activities including
revision of guidelines and refresher training (MoH, official).
MoH officials perceived some of the child-appropriate
dosage formulations recommended by WHO such as
dispersible tablets as a luxury for the already financially
hard-pressed ministry. MoH officials were also aware of
the fact that there were no funds for the decentralized
IMCI activities. Districts were expected to use the Pri-
mary Health Care (PHC) grants to implement the
decentralized IMCI activities and development partners
were expected to supplement. However, the PHC grants
were not enough to cater for all the decentralized IMCI
activities and other already earmarked activities. Jinja
district did not get support for IMCI from development
partners.
As a ministry, we no longer handle IMCI refresher
training. This function was decentralized to the
districts that have to develop a budget to cater for the
refresher training and support supervision. A few
districts have been lucky and some partners like
STRIDES are supporting IMCI. As of now we do not
know what is going on in the districts except where the
partners are operating now (Ministry of Health Official).
Table 2 The process of IMCI Development and implementation landmarks in Uganda
Levels Implementation phases
Adoption phase Early implementation Situation at the time of the study
National In 1995 IMCI selected as the main approach
for Uganda. A 22- member working group
was established for planning, training and
adaptation. IMCI algorithm was adopted to
fit the national health policy and treatment
guidelines
By 1998 there was a national expansion
plan with a pool of 250 trainers, 10 zonal
teams to supervise IMCI implementation.
Donors: World Bank, USAID, UNICEF and
WHO put in resources for early implementation
of IMCI. By 2003 all the districts in Uganda
had been trained in IMCI
Budget constraints and lack of information
about ‘better medicnes for children’ meant
limited national level reflections about policies,
plans, budgets and guidelines for
child-appropriate dosage formulations. No
resources for the sustainability of IMCI in terms
of refresher trainings, revision of job aids and
support supervision. The decentralization of
IMCI to districts minimized the central MoH
role both technically and financially.
Local
(district)
Districts health officials were prepared
in terms of training about IMCI.
Districts were prepared in terms of training
about IMCI.
Resources were not available for the districts.
Districts were getting minimal support from
the ministry in form of PHC grants which
covered a little on support supervision.
Therefore, the districts were not prepared for





Health workers were sensitized on the
new approach of IMCI.
Health workers were trained on the new
approach of IMCI for 3 weeks.
Health workers were no longer receiving
refresher training and support supervision for
IMCI related activities from the district health
team because districts did not have the
financial capacity to do so.
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MoH was also aware of the human resource challenges
especially understaffing and limited number of qualified
health personnel especially in the rural areas. Such staff
needed adequate refresher training and support supervi-
sion to acquaint them with new information about the
global and national treatment policies for children.
Failure to revise the IMCI treatment charts
Despite of the fact that WHO consistently revises the
IMCI algorithm to accommodate new evidence based
medicine, MoH officials admitted that it has not been
possible to adapt new WHO IMCI algorithms to the
Ugandan setting due to funding challenges as already in-
dicated. Other than the WHA recommendation of better
medicines for children, there other national initiatives
such as changes in malaria treatment policies which
were not communicated to the lower cadre staff. All
these were not reflected in the IMCI treatment charts
and this resulted into confusion especially among the
lower level rural based health workers who entirely de-
pend on IMCI treatment charts to diagnose and pre-
scribe medicine to children.
Lack of global and national level efforts to initiate the
integration
Unlike the other initiatives such as malaria treatment
policy, WHO did not initiate national discussions about
child-appropriate dosage formulation and how they
would be integrated into the IMCI framework. MoH ex-
pected external support especially from WHO and
UNICEF to initiate and finance the integration of child-
appropriate dosage formulations.
We did not see any justification for just introducing
child-appropriate dosage formulations into the IMCI
approach without any guidance from theWorld Health
Organization. There were gaps in the information about
the child-appropriate dosage formulations concept
especially regarding where themedicines could be
procured and at what prices. (Ministry of
Health official).
On the other hand, donors had stopped funding
facility based IMCI by the time the resolution of 'bet-
ter medicines for children' was made. The MoH offi-
cials recounted how they had advised donors to
continue to support the facility based IMCI including
procurement of medicines for which donors did not
comply. The discussions about child-friendly medi-
cines only gained momentum in 2012 after the UN
declaration of life- saving priority medicines for chil-
dren. Both government and donors agreed to include
into the mainstream health service delivery system,
lifesaving for children. This was a good opportunity
since all the medicines in the list of priority lifesaving
medicnes for children were recommended in child-
appropriate dosage formulations. In spite of this new
emphasis, MoH officials also confessed that it would
take time before these medicines could be accessed as
there would be need to revise the EMHSLU,
UCG and IMCI treatment charts to reflect ‘better
medicines for children’.
Perspectives about child-appropriate dosage
formulations
Table 3 highlights the context and explanations by
the respondents at different levels about status quo
of child-appropriate dosage formulations within the
IMCI framework in Uganda. The table highlights the
perspectives in the wider context of the three differ-
ent levels (ministry, district and facility) and how
this affected the integration of child-appropriate dos-
age formulations into the IMCI framework. Although
there were some areas of convergence, the perspec-
tives are presented according to the specific respon-
dents: MoH officials, district health officials,
pediatricians and lower level rural based health
workers.
Perspectives from Ministry of Health
The concept of child-appropriate dosage formula-
tions in Uganda centered on liquid oral dosage for-
mulations (syrups) which were deleted from the
EMHSLU 2012 and were for the interim replaced
with tablets for adults that were extrapolated for
children. The reasons for deleting syrups included
high prices and handling challenges. The deleted
syrups were no longer being supplied in the public
health facilities.
We usually find a lot of problems with these
syrups. They are messy, expensive, and difficult to
handle during transportation. They are had to
store especially in remote areas where there is no
power for refrigeration (Ministry of Health
official)
When asked about other child-appropriate dosage
formulations such as pellets, sprinkles and
dispersible tablets, MoH officials stated that lack of
market information and high cost of these formula-
tions repulsed efforts to integrate them into the
IMCI approach. MoH officials generally perceived
some of these formulations to be expensive and this
affected their efforts to integrate them into the
EMHSLU.
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The perspectives of the district health officials
The district officials’ explanations of the failure to integrate
child-appropriate dosage formulations were consistent with
those of the MoH. Lack of funds purportedly affected im-
plementation of the decentralized IMCI activities. While
the district managers were aware of their decentralized
roles in relation to IMCI training and support supervision
of facilities, they were not capable of carrying out the re-
sponsibilities due to lack of resources as indicated in
Table 3. Under the decentralized arrangement, there
was a challenge of understaffing due to the failure of
local government to attract qualified health workers
especially in the rural health facilities. Consequently,
the majority of health workers seeing children in
these facilities were mainly nurses and nursing assis-
tants. Due to their limited medical training and
limited access to information, this category of staff
need constant on- job training and job aids to help
them understand new information. According to the
district officials, this was not happening.
Table 3 Perspectives of respondents about IMCI and child-appropriate dosage formulations
Actors The context The Point of view of the actors
MoH officials • Budget constraints and lack of information about ‘better
medicines for children’ meant limited national level
reflections about policies, revision of guidelines, budgets
and guidelines for child-appropriate dosage formulations
• MoH decentralized refresher training and support
supervision for IMCI for the districts and their
development partners
• Lack of global initiatives to support the resolution of
‘better medicines for children’ at the national level and
challenges of sustainable financing for IMCI
implementation
• When IMCI funding reduced and MoH could no longer
provide oversight and refresher training for IMCI and
these roles were left for local governments under
decentralized services. However, MoH continues to
acknowledge the fact that there were no sufficient
resources for implementing IMCI under the decentralized
arrangement
• Concerns that donors and development partners had
shifted their goals to fund the community based ICCM
program completely leaving out support for IMCI at the
facility level
• Since the markets and prices for some of the child-
appropriate dosage formulations such as sprinkles, pellets
and dispersible tablet were not known. They were per-
ceived to be expensive and therefore not affordable by
the ministry. Other well-known child-friendly formulations
such as syrups were too costly and moreover difficult to
handle and store in a low income setting of Uganda. They
were deleted from the EMHSLU 2012 due to these
reasons.
The district health officials • Underfunding of the decentralized responsibilities in the
health sector
• Donors had shifted interest to ICCM and abandoned
IMCI
• Jinja district was not ready for the decentralized roles of
conducting IMCI refresher training and support
supervision due to financial constraints. They were
concerned about lack of revised IMCI treatment charts.
Centralization of medical supplies to NMS has deprived
the district the opportunities to decide on the
procurement of the right medicines for children
Pediatricians • Pediatricians are limited and are only available in
hospitals
• Pediatricians are supposed to see children who are
referred to them by the lower level health workers
• IMCI is a strategy to be used by the lower cadre staff. At
the moment the approach is not robust enough to
integrate new treatment changes
• The IMCI strategy would benefit from improved IMCI
guidelines that would address evidence based and
child-appropriate dosage formulations
• The Uganda Clinical Guidelines are insufficient and
pediatricians were reportedly referring to other guidelines
such as BNF and the internet to determine treatment.
Prescribe some syrup such as amoxicillin syrup and other
child-friendly syrups available in the private sector. Had an
idea about dispersible tablets but did not use them because




Cognitive Barriers, using outdated IMCI charts, limited
interaction with the MoH officials in terms of support
supervision
• Need refresher training on IMCI, updated guidelines and
evidence based medicines
• Need support supervision to enable them improve their
skills
• Some nursing assistants said that they did not know that
the treatment policy for malaria had changed
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We are expected to carry out refresher training for
different things including IMCI. The PHC grants that
we receive are not enough for the many obligations. So
we can only do a little in support supervision which
also covers a wide range of other things. Refresher
training for IMCI requires a lot of money which is not
available. We are looking forward for some external
support (District Health official, Jinja District).
District officials also underlined challenges of recentra-
lizing procurement and distribution of medicine supplies
to NMS which was supplying medicines that were not
necessarily corresponding to the priorities of the district
and health facilities. There was a general feeling that dis-
tricts have no say about the medicines that are procured
by NMS compared to before when the districts had the
discretion to purchase the medicines they wanted. Dis-
trict official wondered why important medicines for chil-
dren such as syrups were being left out by NMS.
We used to have important syrups to treat malaria and
pneumonia especially among the under-five children
and now there are no more because we depend on NMS
for drug supplies. NMS no longer supplies syrups. They
supply tablets instead. It is now difficult for our
caregivers to administer tablets to children. There are so
many associated problems, dividing the tablets affects
dosing, children refuse to swallow the medicines and if
they do so they can easily vomit (District Health Official,
Jinja district).
Like the ministry, the district officials accentuated the
limitation of unrevised IMCI treatment chart as a refer-
ence material especially for the nursing assistants who
are not sufficiently medically trained but nevertheless
were treating children in most of the low level rural
based health facilities.
In most cases our health workers use guess work and
hearsay from the private sector providers. For quite
some time, despite the changes in treatment policies,
the IMCI guidelines have not been revised. They are
still using the initial IMCI treatment charts which still
refer to chloroquine as the first line treatment for
malaria. They are so outdated. Yet our nursing
assistants have no other reference materials to treat
children other that the unrevised IMCI treatment
charts (District Health Official, Jinja District).
Due to resource constraints and limited opportunities
to decide on procurement, the district officials argued
that they did not control the provision of child–appropriate
dosage formulations. They remain on the receiving end
and accept whatever is distributed by NMS.
Perspectives from the health workers
Health workers who participated in the interviews
were differentiated by their level of training. Level of
training influenced the health workers’ views about
IMCI and child-appropriate dosage formulations.
Health workers interviewed fall into two broad cat-
egories. The first includes pediatricians who are
highly specialized health workers in diagnosing and
treating children. Ideally pediatricians are supposed to
handle referral cases from the lower level health
workers from the outpatient department (in case of
hospitals) and lower level health facilities. In the
Ugandan public health facilities, pediatricians mainly
work in hospitals where they are supposed to handle
complicated cases. The second category included the
rural based and less trained health workers who were
mainly clinical officers, midwives, nurses and nursing
assistants. Ideally, rural based health workers are sup-
posed to treat less severe symptoms using IMCI and
refer severe cases and any other complications to the
pediatricians.
Pediatricians’ perspectives and their practices
The general view from the pediatricians was that IMCI
does not cater for child-friendly medicines due to lack of
a conducive medicine policy environment. Pediatricians
reported that they do not use IMCI approach because
they are consultants for very sick children after their
management using the IMCI has failed. It was therefore
more practical to think of more advanced and inter-
national guidelines to diagnose complicated cases among
children.
For us we are beyond IMCI. We handle problems
where IMCI has failed. We are consultants who are
supposed to read widely. We refer to the internet, the
British National Formulary and for that matter, we
read beyond the Uganda Clinical Guidelines. However,
because the clinical guidelines are not followed (by
some of the lower level health workers) we often
handle children with ordinary conditions and this
increases our patient load (Pediatrician, Jinja regional
referral hospital).
Pediatrician supported provision of child-appropriate
dosage formulations. From their own point of view, the
best child-appropriate dosage formulations were mainly
liquid oral dosage formulations (syrups). They were for
example concerned about the government policy that
phased out syrups that were being used for the treat-
ment of pneumonia and malaria. They argued that some
of the emerging complications and treatment failure
were due to use of medicine formulations that were not
appropriate for children.
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Some of the children referred to us from the lower level
health facilities will have received the right treatment
in terms of the medicines. However, because most of
these will have been given in formulations of tablets,
caretakers usually report difficulties in administration
of the medicines. These difficulties result into
inaccurate dosing sometimes associated with vomiting
of the medicines. Caretakers do not know what to do
when the child vomits. Most of them stop giving the
medicines. We have been hearing these complaints
from the caretakers quite a lot (Pediatrician Jinja
Regional Referral Hospital).
Pediatricians from the regional referral hospital and the
national referral hospitals reported that the Uganda Clinical
Guidelines (UCG) were insufficient for the management of
the prevailing childhood illnesses. They therefore, did not
necessarily prescribe medicines indicated in the UCG.
Pediatricians reported that they often prescribed medi-
cines that were not in the public health facilities but
were nevertheless considered to be child-appropriate by
the pediatricians. When the medicines are not available,
pediatricians said they referred caregivers to procure the
medicines from the private pharmacies and private
clinics where the medicines were available at a cost.
Perspectives and practices rural based health workers
Rural based health workers reported (it was also ob-
served) that they were still using the outdated IMCI
treatment charts of 2001. They had not been oriented
on the new treatment policies for quite some time and
support supervision had accordingly diminished. It was
noted that child-appropriate dosage formulations such
granules, sprinkles and dispersible tablets were not men-
tioned among the key dosage formulations that health
workers used in their daily practice using IMCI. They
were instead familiar with tablets, suppositories for mal-
aria and, injectables for pneumonia and sepsis.
Some of the Nurses and Nursing Assistants who had
been in service for some years said they were initially
trained in IMCI. However, they had also spent a long
time without attending IMCI related refresher courses
and felt that refresher trainings would have informed
them more about new medicines, changes in treatment
regimens, new guidelines and any other new information
about managing childhood illnesses.
We come to learn about these new medicines from our
friends who work in private clinics. Some medicines
are brought here for use when we have never heard
about them. The IMCI charts you see hear are
referring to very old medicines some of which have
already been phased out. We are often confused by
this (Nurse, rural based health facility).
Some of the midwives who were interviewed reported
that they had been left out during the initial IMCI train-
ing perhaps because it was never anticipated that they
would ever interface with children. However, due to staff
shortages, midwives were found treating children. Mid-
wives noted that their work of treating children would
be enhanced if they were also trained on how to use
IMCI charts to treat children.
Health workers reported information gaps due to failure
to update IMCI treatment charts to reflect medicines rec-
ommended by the new treatment policies. Much as the
UCG had been revised from the 2007 to 2010, then later
in 2012, only the in-charges in the rural based facilities
had access to the revised guidelines. Health workers re-
ported experiencing challenges regarding new treatment
policies that were by then not integrated into the IMCI
treatment charts. This, according to some, undermined
their confidence in relation to deciding on which medi-
cines to give. The newly introduced medicines for malaria
were not written anywhere on the IMCI treatment charts
that they were using. For example, while Artemether
Lumefantrine was the first line treatment for malaria rec-
ommended in the new national malaria treatment policy,
the IMCI treatment charts referred to a combination of
fancidar and chloroquine-medicines which had been
phased out by the National Drug Authority. Their other
source of confusion was that the fansidar-chloroquine
combination was also being recommended in the UCG
2010. At the same time, there were other types of anti-
malarial medicines such as artesunate suppository and
artesunate injectable. Despite the artesunate rectal and in-
jectable formulations not being widely available in the
health facilities, health workers often came across them ei-
ther in the private sector or the community. Some inter-
faced with them because they were being channeled
through their health facility to the community for the
ICCM program. Although they were advised by their su-
pervisors to use Artemether lumefantrine for malaria,
health workers had also informally heard about use of rec-
tal artesunate from the community based health workers.
Although rectal artesunate (both injectable and supposi-
tory) was up to date and considered appropriate for chil-
dren, they were often out of stock and health workers did
not know when to use these two formulations. Some
health workers still knew that chloroquine was still the
main medicine for malaria. One of the Nursing Assistants
innocently asked why chloroquine was no longer being
supplied in the health facilities.
The health workers’ understanding of the new treat-
ment protocols varied according to the level of training.
Comparatively, senior health workers especially pediatri-
cians were more conversant with the new treatment pol-
icies than the lower level health workers in the rural
facilities who did not have sufficient information about
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new medicines for children. The missing interactions be-
tween the rural based health workers and their supervisors
who included the district health teams and central level
MoH staff partly explains the health workers’ limited un-
derstanding of new treatment policies. Although medicine
policies for key causes of morbidity among children had
been changing, the transfer of information about new pol-
icies from the global through the national level to the fa-
cilities had not been effective. Besides that, most of the
rural based health workers such as Nursing Assistants said
they did not have access to the revised Uganda Clinical
Guidelines of 2010. In most of the facilities, it was re-
ported (and also observed) that the guidelines were locked
in cupboards of their supervisors who were often absent.
The few lower cadre health workers who had glanced at
the Uganda Clinical Guidelines of 2010 indicated that the
guidelines were too bulky for them to use in their daily
work and for that reason they had put them aside.
These guidelines (Uganda Clinical Guidelines) are too
big. You have to turn so many pages to get to the exact
information about a disease. In addition to that, we
have never been oriented on these guidelines. There
are some technical terms which some of us cannot
understand. We find the IMCI counseling and
treatment charts easy to use. Unfortunately, these
IMCI charts have outdated information where some of
the medicines are no longer recommended (Nursing
Aide rural based health facility Jinja district).
On the other hand, the outdated IMCI treatment charts
were visible with health workers who reported them to be
more user friendly than the UCG. Some of the health
workers wondered why medicines like the combination of
chloroquine and SP which had already been phased out by
the National Drug Authority were still appearing on the
IMCI treatment charts. The same medicines were no lon-
ger being supplied by NMS and there were some health
workers who did not know that chloroquine and SP had
been phased out.
You hear that the treatment of malaria has changed
from chloroquine and SP to ACTs. Our (IMCI
treatment) charts continue to indicate chloroquine
and fansidar for children. By the way we no longer
get chloroquine among the medicines supplied here.
What is happening? (A Nursing Assistant rural
based health facility).
Some of the health workers were not sure of the first
line treatment for pneumonia. They wanted to know
whether amoxicillin and cotrimoxazole should be pre-
scribed interchangeably. They said they were using both
septrine and amoxicillin (depending on what was
available at the time of dispensing) as the first line treat-
ment for pneumonia. The child-appropriate amoxicillin
dispersible tablet was still limited in supply and was
mainly delivered for the donor funded ICCM program.
Dispersible amoxicillin tablets were often withdrawn
from the village health team providers for use in the fa-
cilities to avoid expiry especially because fewer children
were being seen by the community providers. Cotrimox-
azole tablets were on a high demand because it was also
being used for HIV/AIDS prophylaxis.
We are using both cotrimoxazole and amoxicillin as
first line treatment for pneumonia depending on what
is available in stock when the child is brought for
treatment. In most cases, cotrimoxazole (septrine) is
used because it is supplied more regularly. On the
other hand, amoxicillin is rarely used because it is
always out of stock. Much of what we see is a remnant
of what was being taken to the community for ICCM.
We even do not know the medicine which is
recommended for pneumonia. We see some of the
donors supplying amoxicillin to the community. On
the other hand, government concentrates on the supply
of cotrimoxazole. Sometimes we take the remainders of
amoxicillin dispersible from because there are
challenges of storing these medicines in the community
for a long time. They can easily expire before use. In
any case, we are seeing many more children here than
they see in the community (Clinical officer, in-charge
of a rural based health facility).
Rural based health workers had limited knowledge
about the globally recommended ‘child size’ medicines
and child-appropriate dosage formulations concepts.
There was a consistent affirmation by the health workers
indicating that IMCI treatment charts and the clinical
guidelines neither referred to ‘child-appropriate’ dosage
formulations’ nor the ‘child size medicines’. In spite of
this limitation, health workers presented informative
viewpoints about the different dosage formulations they
were using to treat children. Health workers in the rural
areas highly commended IMCI as a suitable program for
children but also hastened to add that the approach had
flaws: lack of updated guidelines; missing support super-
vision and, lack of refresher trainings. They echoed lack
of child-friendly medicines in the assortment of medi-
cines supplied by NMS.
The rural based health-workers’ viewed appropriate-
ness of dosage formulations in terms of being easy to
prescribe, dispense and administer. In their practice,
they came across ordinary tablets and capsules, oral sus-
pension powders and a few dispersible tablets. They also
reported using injectables and suppositories to treat chil-
dren under severe conditions. From the experiences they
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shared, formulations in tablet forms and capsules were a
challenge for children to swallow. Yet tablets and cap-
sules were the most supplied by government for chil-
dren. Rural based health workers also expressed their
opinions about formulations which they though were
child-friendly. These were discussed with reference to
the common diseases of malaria and pneumonia. For
malaria, health workers maintained that coartem (Arte-
mether lumefantrine) was child-appropriate in terms
strengths. They do not have to split a tablet of coartem
even for an infant. However, like any other tablet, Arte-
mether lumefantrine has to be crushed before being ad-
ministered to the child. Artemether lumefantrine they
were using was not dispersible in water like the ones
that were being provided in the community and hence
this type was diffecult for children to swallow. Therefore,
rural based health workers said they have often advised
caregivers to crush the tablets in order to make them
suitable for children. Even when broken into pieces,
some health workers noted that tablets were still difficult
for children to swallow especially when the tablets are
bitter. Regarding pneumonia medicines, health workers
complained about lack of septrine syrup in the health fa-
cilities. The most available was the adult size of 480 mg.
As a result, health workers said they were breaking the
big tablets of septrine into smaller pieces before admin-
istering them to children. Despite amoxicillin being the
recommended first line medicine for pneumonia, the
child-appropriate dispersible amoxicillin tablets which
were available in only a few of the health facilities as rem-
nants of what was used in the community. Some of the
health workers admitted having limited understanding of
what dispersible tablets were and how they are used. Some
were concerned because they did not see dispersible tab-
lets being mentioned anywhere in the Uganda Clinical
Guidelines and the IMCI charts they were using.
We hear dispersible tablets being talked about, but we
have not seen anywhere where they are written
(Nursing Assistant, rural based health facility)
Perhaps due to limited knowledge and limited publicity,
dispersible tablets were not considered as themost important
as syrups, suppositories, injectables and ordinary tablets.
There were concerns that liquid oral formulations
commonly referred to as syrups were missing and yet ac-
cording to the health workers they are the best for chil-
dren. The common “syrups” that the health workers had
heard about were for septrine, amoxicillin and chloro-
quine. There were a few rural based health workers who
were critical of syrups and said that they were problem-
atic because they were too expensive and difficult to
store and that was the reason why they were not being
procured by government.
Sometimes there are some medicines whose
consumption is low. In such cases, these are challenges
of storage which makes the medicine susceptible to
being damaged if they are syrups (Nurse, a rural
based health facility).
The most commonly mentioned liquid oral formula-
tions were metronidazole syrup used to treat diarrhea
and nevirapine syrup for prevention of mother to child
transmission. Metronidazole syrup was being supplied in
all the health facilities. Health workers wondered why
metronidazole syrup was regularly supplied in most of
the health facilities and yet other important syrups for
malaria and pneumonia were not provided. Although
they had been deleted from the EMHSLU, syrups for
septrine and amoxicillin were still perceived by health
workers as critically needed for treating children and the
concern was that the only available formulation for sep-
trine was the tablet of 480 mg tablets meant for adults
as earlier discussed. The available Amoxicillin capsules
were perceived to be unsuitable for children.
Ok, I say syrups are expensive fine: but they should
add in a few syrups especially antibiotics such as
septrine and amoxicillin so that we can continue with
them. We only have septrine tablets of 480 mg which
are too big for these children. I think it can help if
there is septrine syrup instead. The rest of the
medicines can remain as tablets (a Nurse in a rural
based health facility).
Injections were reported to be highly available and
highly utilized for treating children especially for severe
pneumonia conditions. Injections were rated as very im-
portant especially by the rural based health workers and
were being used when ‘syrups’ were not available
and were preferred for those children who vomit oral
medicines.
For pneumonia, we always have problems with the
medicines in stock. We mainly have septrine which is
too big for the child to swallow. Septrine syrup would
be ideal but currently syrups are not being provided by
government and we do not know why. We also have
amoxicillin capsules which are the most available but
they are difficult for children to swallow and they are
meant for adults. Therefore, for pneumonia, we often
use injection of x-pen which is not allowed, we just
need to use it for pre-referral treatment. We are forced
to use it especially when the child is vomiting (Nursing
Assistant in a rural based facility).
In a nutshell, rural based health workers persistently
emphasized the fact that, the treatment guidelines and
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the IMCI treatment charts were not clear about child-
appropriate formulations. Despite being the main ap-
proach used to diagnose and treat children, health
workers rightly argued that IMCI had nothing to do
with chid-appropriate dosage formulations. Only names
of medicines were simply referred to as oral, injectable
and suppository. Categories of oral medicines formula-
tions which are child-friendly are not referred to in the
guidelines.
Discussion
The overarching assumption for the WHA resolution
of ‘better medicine for children’ was that beneficiary
countries would adopt this recommendation into their
policy and implementation frameworks. The study de-
sign was based on the premise that child-appropriate
dosage formulations are the best option to improve
prescription, dispensing and administration of medi-
cines to the under-five population. Findings from the
qualitative inquiry at the ministry; district and facility
levels established that there has been no integration of
child-appropriate dosage formulations into the IMCI
approach in Uganda. From the perspectives of the re-
spondents at the three levels, 3 related explanations for
failure to integrate are apparent: (1) resource con-
straints that affected persistent implementation of the
IMCI program (2) gaps in the global and national efforts
to integrate child-appropriate dosage into the Ugandan es-
sential medicines list (3) cognitive gaps and information
distortions that have undermined health workers’ confi-
dence in prescribing, dispensing and administering medi-
cines to children while using outdated IMCI treatment
charts.
Resource constraints and persistent implementation of
IMCI
Resource constraints were constantly referred to in the
perspectives that were explored at the national, district
and facility levels. Resource constraints question can be
viewed in two dimensions. The first dimension was that
whereas IMCI is the main approach used to manage
childhood illnesses in Uganda, it has not been sufficiently
funded to address ever-changing global policy prescrip-
tions such as the integration of chid-appropriate dosage
formulations. In reference to the theoretical framework,
resource constraint barrier was highlighted as a barriers
by Tansella &Thornicroft (2009) in their three phases of
implementation model for evidence based clinical prac-
tices [12].
Due to resource constraints, MoH could not mutually
adjust the health system to meet the new global demand
of child-appropriate dosage formulations. Therefore, the
recommendation for ‘better medicines for children’ came
at a time when resources for supporting IMCI had
already dwindled. Lack of sustainable funding for IMCI
undermined its effectiveness in terms of the integration
of child-appropriate dosage formulations.
The second dimension was that right from its inception,
the recommendation for ‘better medicines for children’
later coined as ‘child-appropriate dosage formulations’, did
not receive specific donor attention. Except for the
Melinda Bill gates Foundation which facilitated piloting of
the child size medicine in three countries of Ghana, India
and Tanzania, there were no other global efforts to market
the concepts of child-appropriate dosage formulations.
The idea of child-appropriate formulations remained in
the UN (UNICEF and WHO) circles for quite long and
did not gain global prominence until the UN declaration
of the ‘essential commodities and lifesaving priority medi-
cines for children’.
Dependence on external funding for critical programs
such as IMCI has done a disservice in some aspects.
Interestingly, bypassing the national systems, largely ig-
noring the existing policies and medicine supply sys-
tems, development partners in Uganda initiated and
supported supply of child-appropriate dosage formula-
tions to the community [7]. Although this marked the
beginning of the era of child-appropriate dosage formu-
lations in the country, failure to mainstream the support
through IMCI the main approach for treating children
and due to failure to revise policy provisions to reflect
child-appropriate dosage formulations [8], the initiative
from the development partners left a lot desired. The
availability and utilization of child-appropriate lifesaving
and priority medicines for children continued to remain
low in public facilities [9]. In the same way, due to lack
of funding, the sustainability of IMCI, which was initially
a heavily donor funded program, became uncertain.
The findings of this study support the argument of
Tansella and Thornicroft that resources are critical
even during the final phases of projects [12]. Similarly,
Hogwood and Gunn (1984) argued that external cir-
cumstances to the implementing agency may impose
crippling effects if there is no adequate time and re-
sources for continuity [13].
At the time when resources were scarce MoH
decentralized some of the key IMCI activities such as
refresher training, support supervision to the district
without decentralizing commensurate resources. It is
not surprising therefore that these activities were not
implemented by the district. According to Walt
(1994), decentralization of responsibilities without the
associated resource requirements may make local au-
thorities vulnerable to policies which are not cost ef-
fective. On the other hand, decentralization of
financial resources can help enforce the guidelines
and other elements of the packages such as support
supervision and refresher courses [14].
Nsabagasani et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:22 Page 12 of 16
The success of the integration of child-appropriate
dosage formulations will largely depend on the capacity
of the health system to enforce compliance. Health sys-
tem strengthening was anticipated as one of the funda-
mental elements of the IMCI strategy [21, 22]. This
study supports the argument that dynamic and strong
health systems would enable the system to achieve im-
proved health outcomes [23]. In Uganda, there have
been more investments in the ICCM with diminishing
support for another equally important component, the
facility based IMCI [7]. Notwithstanding the fact that
the facility based IMCI and ICCM should be well inte-
grated if it is to have an impact on mortality. In Uganda,
as a result of this gap, the expected efficiency and effect-
iveness of the IMCI are not being much felt. While the
community-based initiatives extend the delivery of inter-
ventions in remote areas where health services are hard
to access, strengthening national health systems should
be the long-term aim [24]. Health systems bottlenecks
are a formidable challenge in the rural based health facil-
ities in Uganda and this directly affects integrating child-
appropriate dosage formulations. As a matter of fact, the
health systems' gaps in Uganda who include lowly trained
health personnel who have not been oriented about new
medicines, whose IMCI treatment charts are outdated and
in the context of limited supply of child-appropriate dos-
age formulations and challenges of referral explain the
failure to easily integrate child-appropriate dosage for-
mulations into IMCI. A study elsewhere shows a similar
pattern regarding IMCI implementation whereby the
workload, medicine supplies and poor supervisory mecha-
nisms undermine the program [25].
Due to resource constraints, IMCI remains an unfinished
business in the clinical practice in Uganda. Tansella &Thorni-
croft (2009) highlight the need for sustainable: advocacy, fi-
nancial support, and continuous staff training and review of
the information technology. This did not happen in the case
of Uganda because IMCI was funded in the initial stages by
the donors and this funding stopped later. Government was
unable to sustain all the IMCI core activities that were initially
supported by donors. In the end, the globally generated seeds
of child-appropriate dosage formulations landed on the bare
ground since IMCI as a key framework for treating children
was not adequately funded. Tansella and Thornicroft (2009)
in their framework about translation of evidence into prac-
tice have contended that the greatest impact of a policy is not
adoption per se but rather from the long-term implementa-
tion of the practice where resources are key [12]. Hogwood
and Gunn (1984) added that the combination of resources is
amust for the implementation to take place [13].
Lack of global and national effort
MoH officials attributed lack of integration of child-
appropriate dosage formulations to gaps in the global and
national effort. Although the IMCI algorithm at the global
was adjusted by WHO to take care of ‘better medicines
for children’, this did not happen at the national level in
Uganda. There were no official discussions involving re-
cipient countries and WHO about how to introduce child
size medicines in Uganda [7]. It has been reported that
changes in Malaria treatment policies were largely influ-
enced by WHO active involvement in financing and initi-
ating local discussions about the new policies [26]. For the
integration to take root, it would have been necessary at
the national level to develop a policy framework for inte-
grating these medicines into the essential medicines list
and clinical guidelines. Macleod Stuart and colleagues
(2013) argue that it is necessary to update clinical guide-
lines, train health workers accordingly about the need to
integrate child-appropriate dosage formulations into the
essential medicines lists and the standard treatment guide-
lines which would guarantee knowledge transfer and dis-
semination of the new medicine information [27]. The
disarticulation between IMCI approach in Uganda and the
global recommendations that emphasize child-appropriate
medicine formulations [1, 11] was apparent. This disar-
ticulation has been due to lack of specific policy focus on
child-size medicines both in the essential medicines lists
and the Uganda clinical guidelines (UCG) [8]. The Uganda
government failed to formally adopt the global policy on
child-appropriate dosage formulations [7]. Eventually this
limited the avenues for IMCI to address the global re-
quirement of integrating child-appropriate dosage formu-
lations. For example, the Uganda Clinical Guidelines of
2010 and 2012 were silent about child-appropriate dosage
formulations.
There was concern that quality and effective of treat-
ment of children less than 6 years of age cannot be real-
ized without integrating the child-appropriate dosage
formulations into the essential medicines lists. World-
wide essential medicines lists are considered vital for pri-
oritizing medicines to procure. Holloway and Henry
have shown that essential medicines along with training
on standard treatment guidelines are associated with
quality of medicine use in many countries [28]. In
Uganda, child-appropriate dosage formulations are not
among the essential medicines and worst still, health
workers are not regularly oriented about the global
changes in the medicines for children. Similarly, in
South Africa health workers found training in IMCI in-
formative and reportedly increased their skills for man-
aging the sick children. Follow up visits would help
encourage correct practice and motivate the newly
trained IMCI practitioners [29].
The cognitive gap among health workers
Pediatricians were more confident about the Uganda na-
tional treatment policies of the key childhood illnesses
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and were also able to access state of art international
standards for the management of childhood illnesses.
However, pediatricians are very few and are mainly avail-
able in the hospitals. On the contrary, rural based lower
cadre health workers such as Nursing Assistants did not
have sufficient information about new treatment proto-
cols. This information gap was associated with lack of
revised guidelines, lack of refresher training and gaps in
information mainstreaming when new treatment proto-
cols are introduced through vertical programs such as
the presidential malaria initiative. In this initiative, new
medicines for treating malaria were recommended but
were not reflected in the IMCI treatment charts and
clinical guidelines. Medicines recommended in the clin-
ical guidelines as first line treatment for malaria and
pneumonia among under-five were outdated medicines
which were also not even child-friendly [8]. At the same
time, the new malaria treatment policies proposed
through the vertical program of presidential malaria ini-
tiative were not effectively communicated to the lower
cadre staff in rural based facilities. This is because of the
limited integration of these vertical programs into the
general health care delivery systems such as IMCI. Un-
less the issue of new knowledge is addressed in the IMCI
approach to take care of evidence based medicines and
new approaches to management of childhood illnesses,
IMCI will eventually become irrelevant and will be taken
over by vertical programs such as ICCM and malaria
programs as has been the case before. Innovative solu-
tions may be necessary to ensure that guidelines are up-
dated to reflect child-appropriate medicines and at the
same time health workers’ skills should be updated and
maintained [29].
Lack of information affects easy understanding of new
developments about medicine policies. Okungu and Gil-
son (2014) argued that effective health policy communi-
cation is important for the uptake of new drug
interventions and adherence to treatment regimens [30].
There was confusion about first line medicines due to
information gap resulting from the failure to update the
IMCI treatment guidelines, missing refresher courses
and limited support supervision. It has been argued that
development and implementation of (evidence-based)
clinical practice guidelines is one of the promising and
effective tools for improving the quality of care for chil-
dren [31] especially when introduced in the context of
rigorous evaluations and subsequent updates [32]. Some
of the good attributes of clinical guidelines include an
explicit description of the scientific evidence for which
the recommendation is available; evidence that is
straightforward and not conflicting; and when the evi-
dence is based on relevant aspects of care in daily prac-
tice [33]. At the global level, the most recent version of
IMCI guidelines was produced in 2014. Nevertheless,
the new version is still vague about child-appropriate
formulations. For example, in the UCG there are recom-
mendations such as ‘give oral amoxicillin for 5 days’ on
page 2 of the UCG or ‘give first line oral antimalarial’ on
page 4 of UCG [34]. The IMCI treatment charts that
were being used in all the rural based health facilities by
the time of the study had not been updated since 2001.
This explains the confusions and lack of confidence
especially among the lower level rural based health
workers.
Policy implications
According to the Health Sector Strategic and Investment
Plan III, IMCI remains the main approach in the man-
agement of childhood illnesses in Uganda [6]. In reality,
IMCI is the most appropriate approach for the rural
based health facilities where children are treated by low
cadre health workers. Therefore, IMCI should constantly
receive adequate attention during the policy develop-
ment, planning, budgeting and implementation pro-
cesses. Without sufficient investments into the IMCI
core activities, the expected gains from IMCI will not be
achieved. Core investments should include regular adap-
tation of new generic guidelines from WHO, sufficient
facilitation in terms of training, support supervision and
regular to ensure that there is an environment in which
health workers can apply their child care skills [35]. It
also means that all the vertical programs such as the
presidential malaria initiative and ICCM should be
aligned with and integrated into the IMCI program
whereby guidelines of these vertical programs are part
and parcel of the IMCI treatment charts. Pediatricians
continue to prescribe liquid oral formulation (syrups)
which are not readily available in the public facilities and
caretakers have to purchase them at high costs. The im-
plication is that some of the caregivers who cannot af-
ford the medicines might have to forego the treatment
or procure under dose because they cannot afford. This
infringes on the rights of the poor to health services.
Conclusion
The IMCI package for managing childhood illnesses in
Uganda does not include the global recommendation of
‘better medicines for children’. The poorly funded IMCI
strategy has continued to stagnate due to lack of re-
sources for updating the guidelines, procure evidence
based medicines, conduct refresher training and support
supervision for health workers. This stagnation con-
tinues to undermine appropriate and effective adminis-
tration of medicines to children. The missing child-
appropriate dosage formulations in the EMHSLU and
UCG undermine low cadre rural based health workers
efforts to appropriately treat children using the IMCI ap-
proach. There are still challenges in prescribing,
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dispensing and administration of tablets and capsules to
children under-five. Depending on their level of medical
training, health workers have come up with strategies for
mitigating the challenges of administration of adult medi-
cines to children. Lower cadre health workers prefer using
injections and suppositories which they more appropriate
for children who vomit. When revising the clinical guide-
line, it is important to seek the views of those providers
managing children especially lower cadre staff who have
narrow choices of medicines, have limited information
about new medicnes and are also faced with challenges of
medicine formulations that are inappropriate for children.
Recommendations
Both government and development partners should invest
more into the IMCI strategy from a health systems ap-
proach to enable the systems to respond positively to the
emerging global demands for child-appropriate dosage for-
mulations. This would require more budget allocations to
the child health division and other relevant departments.
The IMCI treatment charts should be updated regularly to
reflect child-appropriate dosage formulations. It will also
necessitate revisiting the EMHSLU to reflect child-
appropriate dosage formulations based on new evidence.
There should be adequate budget provisions for refresher
training and support supervision for the health workers on
new evidence-based and national treatment policies for the
common childhood ailments. More studies are needed to
explore the experiences of the caregivers about access and
use of child-appropriate dosage formulations.
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